June 29, 2011 08:31 ET

Equity Research on Perrigo Co. and Auxilium Pharmaceuticals Inc. - Some Drug Related Products Sector Benefit From Shift to Generics During Hard Times

NEW YORK, NY--(Marketwire - Jun 29, 2011) - has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Drug Related Products industry and are offering free analytical research on Perrigo Co. (NASDAQ: PRGO) and Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL). Register with us today at to have free access to these research reports.

While several factors have made the current environment very difficult for companies in the Drug Related Products sector, with companies like Auxilium Pharmaceuticals Inc. reaching a 52-week low recently, it has also motivated some trends that have sharp benefits. Auxilium Pharmaceuticals Inc. report is accessible for free by registering today at is the Ultimate Trading Environment for investors. If you are considering owning Perrigo Co. and Auxilium Pharmaceuticals Inc. then you should sign up for a free membership and our complimentary reports today at Over the last 5 years our returns outpaced any of the major indexes. Sign up today to find out what you are missing.

The economic recession has had a major effect on the mentality of consumers. While many had been previously willing to pay extra to get brand-name drugs, the downturn put a great deal of strain on shopper's budgets, sending them to the shelves in search of savings. With the lower price point initially causing consumers buying the generics, many realized that there wasn't as much of a discrepancy in quality as the price difference suggested. Get your free reports on Perrigo Co. and Auxilium Pharmaceuticals Inc. at There is no commitment to join.

This trend towards generics has been great for companies like Perrigo Co. which produces store-brand drugs for retailers like Wal-Mart, Target, CVS, and Walgreen among others. Store brands currently hold around 30% market share in the over the counter space and Perrigo's CEO believes this could ultimately grow to over 40%. The movement of many prescription medicines to the OTC market should also help Perrigo and companies in the sector that sell generics. Perrigo Co. report is accessible for free by registering today at

The two Drug Related Products stocks research reports are available for free by signing up now on


Shine's Rooms is the brain child of David Shine, a 13 year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.

To view our disclaimer, visit this link

Contact Information